We are live on ! Find out more
MBIO icon

Mustang Bio
MBIO

30 hedge funds and large institutions have $827K invested in Mustang Bio in 2024 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

299% more capital invested

Capital invested by funds: $207K → $827K (+$619K)

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

20% more funds holding

Funds holding: 25 → 30 (+5)

0.14% more ownership

Funds ownership: 0.05% → 0.19% (+0.14%)

Holders
30
Holders Change
+5
Holders Change %
+20%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
6
Reduced
3
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$796K
2
UBS Group
UBS Group
Switzerland
+$21K
3
Renaissance Technologies
Renaissance Technologies
New York
+$19.3K
4
HWM
HB Wealth Management
Georgia
+$14.8K
5
HF
HRT Financial
New York
+$12.1K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$26.5K
2
KOC
Koss-Olinger Consulting
Florida
-$23K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$15.6K
4
HighTower Advisors
HighTower Advisors
Illinois
-$5K
5
JPWM
Jamison Private Wealth Management
Georgia
-$3.53K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$638K +$796K +72,131 New
Geode Capital Management
2
Geode Capital Management
Massachusetts
$50.3K +$8.6K +779 +16%
HWM
3
HB Wealth Management
Georgia
$19.9K +$14.8K +1,340 +168%
UBS Group
4
UBS Group
Switzerland
$17.8K +$21K +1,901 +1,697%
Renaissance Technologies
5
Renaissance Technologies
New York
$15.5K +$19.3K +1,750 New
BlackRock
6
BlackRock
New York
$14.8K – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$13.3K – – –
HF
8
HRT Financial
New York
$9K +$12.1K +1,098 New
Two Sigma Investments
9
Two Sigma Investments
New York
$7.2K +$8.99K +814 New
TSS
10
Two Sigma Securities
New York
$6.41K +$7.99K +724 New
XT
11
XTX Topco
Cayman Islands
$5.03K +$6.28K +569 New
Citigroup
12
Citigroup
New York
$4.54K +$5.66K +513 New
PI
13
PFG Investments
New York
$3.92K – – –
Wells Fargo
14
Wells Fargo
California
$3.54K +$2.43K +220 +122%
Northern Trust
15
Northern Trust
Illinois
$2.99K – – –
State Street
16
State Street
Massachusetts
$2.83K – – –
Goldman Sachs
17
Goldman Sachs
New York
$2.35K +$2.92K +265 New
VPW
18
Variant Private Wealth
Virginia
$2.3K +$2.87K +260 New
Morgan Stanley
19
Morgan Stanley
New York
$2.08K +$640 +58 +33%
TRCT
20
Tower Research Capital (TRC)
New York
$1.91K -$44 -4 -2%
Macquarie Group
21
Macquarie Group
Australia
$1K – – –
HI
22
Harbour Investments
Wisconsin
$679 – – –
Fidelity Investments
23
Fidelity Investments
Massachusetts
$545 -$1.56K -141 -69%
Bank of America
24
Bank of America
North Carolina
$75 +$11 +1 +14%
BNP Paribas Financial Markets
25
BNP Paribas Financial Markets
France
$60 +$77 +7 New
1
2

MBIO Hedge Fund Activity: Q4 2024 in Review

30 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q4 2024, worth a combined $827K — up 299% from $207K a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new MBIO positions and 6 closed out — a net gain of 5 holders — while 6 added to existing stakes and 3 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $796K. The largest seller was Citadel Advisors, exiting entirely with an estimated $26.5K sold.

  • 30 institutional investors held Mustang Bio (MBIO) as of Q4 2024, up from 25 in Q3 2024.
  • Funds reported $827K of Mustang Bio stock for Q4 2024, up 299% quarter-over-quarter.
  • 11 funds opened new Mustang Bio positions in Q4 2024 and 6 closed out, a net change of +5 holders.
  • The largest Mustang Bio buyer in Q4 2024 was Armistice Capital, an estimated $796K added.
  • The largest Mustang Bio seller in Q4 2024 was Citadel Advisors, an estimated $26.5K sold.

Based on aggregated 13F filings for Q4 2024.